Bypassing Immune Rejection in Stem-Cell-Based Therapies – San Francisco Chronicle (press release)
|
Bypassing Immune Rejection in Stem–Cell-Based Therapies
San Francisco Chronicle (press release) In a recent study published by STEM CELLS, a research group from Stanford University describes a novel regimen for quashing the immunologic barrier with a short-course treatment of two costimlation-adhesion blockade agents, to allow engraftment of … Scientists have discovered the key to treating heart failure.Belfast Telegraph A Pew Poll is a Good Sign for Small Cap Stem Cell Stocks (STEM, NBS, CUR …<font size="-1" …read more    |
